中国实用外科杂志

中国实用外科杂志

• 专题笔谈 • 上一篇    下一篇

ERCP术后胰腺炎的预防策略

郭学刚，罗    辉，郑    亮   

  1. 第四军医大学西京消化病医院内镜中心，陕西西安710032
  • 出版日期:2017-08-01 发布日期:2017-07-25

  • Online:2017-08-01 Published:2017-07-25

摘要：

胰腺炎是内镜逆行胰胆管造影（ERCP）术后最常见和最严重的并发症之一。目前，非甾体类抗炎药物（吲哚美辛栓或双氯芬栓）纳肛和预防性胰管支架植入是行之有效的ERCP术后胰腺炎（PEP）预防措施。优化ERCP围手术期管理(术前风险评估，术中风险控制，术后积极治疗)，可有效降低PEP风险。

关键词: 内镜逆行胰胆管造影, 胰腺炎, 非甾体抗炎药, 支架

Abstract:

Prevention strategies of post-endoscopic retrograde cholangiopancreatography pancreatitis      GUO Xue-gang, LUO Hui, ZHENG Liang. Endoscopy Center, Xijing Hospital of Digestive Diseases, the Fourth Military Medical University, Xi’an 710032, China
Corresponding author: GUO Xue-gang, E-mail：gxuegang@
fmmu.edu.cn
Abstract     Pancreatitis is the most common and serious complication of endoscopic retrograde cholangiopancreatography (ERCP). Rectal non-steroidal antiinflammatory drugs (NSAIDs) (indomethacin or diclofenac) and pancreatic stents are effective preventions of post-ERCP pancreatitis. Optimal ERCP perioperative management (preoperative risk evaluation, intraoperative risk management, postoperative active treatment) can reduce PEP risk effectively.

Key words: endoscopic retrograde cholangiopancreatography, pancreatitis, non-steroidal antiinflammatory drugs, stent